Strides Pharma Science Ltd’s Chestnut Ridge facility received four procedural FDA observations, with no impact on supply. Shares of Strides Pharma Science Ltd ended lower on Wednesday, December 24, by 3.59% at ₹936 on the NSE.
Strides Pharma Science Ltd’s Chestnut Ridge facility received four procedural FDA observations, with no impact on supply. Shares of Strides Pharma Science Ltd ended lower on Wednesday, December 24, by 3.59% at ₹936 on the NSE.